Lateral Flow Assay Market Size (2024 - 2029)

The lateral flow assay market is projected to experience growth due to its increasing adoption for diagnosing infectious diseases, HIV, and cancer, driven by the need for effective and accessible diagnostic methods. The market's expansion is further supported by technological advancements in lateral flow assays, such as novel signal enhancement techniques and improved quantification systems. The COVID-19 pandemic has also accelerated the use of these assays, particularly in settings with limited laboratory facilities. Government initiatives and increased awareness about infection control and home diagnostic systems are expected to bolster the market. However, challenges like regulatory delays and the potential for false results may hinder market growth.

Market Size of Lateral Flow Assay Industry

Lateral Flow Assay Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 10.46 Billion
Market Size (2029) USD 14.79 Billion
CAGR (2024 - 2029) 7.18 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Lateral Flow Assay Market Major Players

*Disclaimer: Major Players sorted in no particular order

Lateral Flow Assay Market Analysis

The Lateral Flow Assay Market size is estimated at USD 10.46 billion in 2024, and is expected to reach USD 14.79 billion by 2029, growing at a CAGR of 7.18% during the forecast period (2024-2029).

The factors driving the growth of the market are increased demand for point-of-care testing (POC) with technological advancements, the rise in the adoption of home-based devices, and the global incidence of infectious diseases. For instance, according to the study article published in Asian Biomedicine in December 2023, Lateral Flow Assays (LFAs) are considered ideal POC devices. Consumers and regulatory authorities prefer them the most for disease diagnostics globally. LFAs have a simple designated structure, making them portable and equipment-free. LFAs, with their comparatively low manufacturing costs, are priced affordably in the market. Thus, studies like this emphasize the significant benefits of point-of-care testing in diagnosing diseases, which is expected to contribute to Lateral Flow Assays Market growth during the forecast period.

Also, the growing prevalence of infectious diseases such as HIV, Tuberculosis, and Acute Hepatitis and increasing demand for testing kits like Rapid Diagnostic Kits will boost the market during the forecast period. For instance, according to the United Nations Programme on HIV/AIDS Global AIDS Update 2024, globally, 39.9 million people lived with HIV at the end of 2023, an increase of 2.3% compared to 2022. Thus, with the high prevalence of HIV, the demand for its testing increases, thereby driving the Rapid Diagnostics Market growth during the forecast period.

Additionally, the new research and studies and technological developments in the Lateral Flow Assay Market are expected to drive the growth of the market. For instance, an article published in Multidisciplinary Digital Publishing Institute in October 2022 highlighted advancements in Lateral Flow Immunoassays. The highlighted developments are crucial for detecting adulteration and toxic substances in food and drug samples by integrating robust sensors boasting ultra-high reproducibility. Thus, such technological developments are increasing the adoption of LFAs, thereby driving the growth of the market.

Consequently, driven by rising demand for point-of-care testing, technological advancements, and significant disease burden, the market is poised for good growth during the forecast period, according to current Lateral Market Trends. However, stringent and tedious regulatory frameworks, leading to delays in the approval of products, and the risk of false results and reluctance toward these products among people in emerging nations are expected to hinder the growth of the market during the forecast period.

Lateral Flow Assay Industry Segmentation

As per the scope of the report, lateral flow assays, also referred to as lateral flow immunochromatographic assays, are cellulose-based devices used to detect the presence of a target analyte in the sample without the need for specialized and costly equipment and highly skilled healthcare professionals for their operation.

The lateral flow assay market is segmented by application, technique, product, end user, and geography. By application, the market is segmented into clinical testing, drug abuse testing, and other applications. The clinical testing segment includes pregnancy testing, influenza testing, tuberculosis, D-dimer testing, and other clinical testing. By technique, the market is segmented into sandwich assay, competitive assay, and multiplex assay. By product, the market is segmented into lateral flow readers and kits and reagents. The lateral flow readers include digital/mobile readers and benchtop readers. By end user, the market is segmented into home care, hospitals and clinics, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for all the above segments.

By Application
Clinical Testing
Pregnancy Testing
Influenza Testing
Tuberculosis
D-dimer Testing
Other Clinical Testing
Drug Abuse Testing
Other Applications
By Technique
Sandwich Assay
Competitive Assay
Multiplex Assay
By Product
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers
Kits and Reagents
By End User
Home Care
Hospitals and Clinics
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Lateral Flow Assay Market Size Summary

The lateral flow assay market is poised for significant growth over the forecast period, driven by the increasing global prevalence of infectious diseases, HIV, and cancer, which necessitate effective diagnostic methods. The COVID-19 pandemic has notably accelerated the adoption of lateral flow tests due to their portability, ease of use, and rapid results, making them ideal for mass screening programs, especially in regions with limited laboratory infrastructure. Technological advancements in lateral flow assays, such as novel signal enhancement techniques and improved quantification systems, have further bolstered market expansion. The market is also witnessing increased government participation in controlling infectious disease outbreaks and raising awareness about diagnosis and prevention, which is expected to contribute to its growth.

North America is anticipated to dominate the lateral flow assay market, supported by a high incidence of infectious and chronic diseases and a robust healthcare infrastructure. The United States, in particular, is expected to hold a significant market share due to its large patient pool and increased disposable income. The region's market growth is further fueled by the rapid spread of infectious diseases and the implementation of mass screening programs during the pandemic. The market is moderately competitive, with major players like Abbott Laboratories, Hologic Inc., and Quidel Corporation expanding their presence through strategic mergers, acquisitions, and the introduction of new diagnostic products. These developments are expected to sustain the market's upward trajectory in the coming years.

Explore More

Lateral Flow Assay Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increased Demand for Point-of-Care Testing with Technological Advancements

      2. 1.2.2 Rise in Adoption of Home-based Devices, along with Global Incidence of Infectious Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent and Tedious Regulatory Framework that Delays the Approval of Products

      2. 1.3.2 Risk of False Results and Reluctance Toward these Products among the People in Emerging Nations

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Application

      1. 2.1.1 Clinical Testing

        1. 2.1.1.1 Pregnancy Testing

        2. 2.1.1.2 Influenza Testing

        3. 2.1.1.3 Tuberculosis

        4. 2.1.1.4 D-dimer Testing

        5. 2.1.1.5 Other Clinical Testing

      2. 2.1.2 Drug Abuse Testing

      3. 2.1.3 Other Applications

    2. 2.2 By Technique

      1. 2.2.1 Sandwich Assay

      2. 2.2.2 Competitive Assay

      3. 2.2.3 Multiplex Assay

    3. 2.3 By Product

      1. 2.3.1 Lateral Flow Readers

        1. 2.3.1.1 Digital/Mobile Readers

        2. 2.3.1.2 Benchtop Readers

      2. 2.3.2 Kits and Reagents

    4. 2.4 By End User

      1. 2.4.1 Home Care

      2. 2.4.2 Hospitals and Clinics

      3. 2.4.3 Other End Users

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Lateral Flow Assay Market Size FAQs

The Lateral Flow Assay Market size is expected to reach USD 10.46 billion in 2024 and grow at a CAGR of 7.18% to reach USD 14.79 billion by 2029.

In 2024, the Lateral Flow Assay Market size is expected to reach USD 10.46 billion.

Lateral Flow Assays Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)